Editors

Etty (Tika) Benveniste is professor and chairman of the Department of Cell Biology at the University of Alabama at Birmingham. She received her Ph.D. in immunology from the University of California, Los Angeles, in 1983, and was a postdoctoral fellow in the laboratory of Dr. Jean Merrill, Department of Neurology, UCLA, from 1983 to 1986.

Dr. Benveniste has received numerous honors and awards, including NIH Training Grant Fellowships (1982-1983, 1984-1985); a postdoctoral fellowship award from the National Multiple Sclerosis Society (1986-1987); Plenary Lecturer, Fourth International Congress of Neuroimmunology (1994); Plenary Lecturer, UCLA Neurobiology of Disease Conference (1995); Member and Plenary Lecturer, Sixth International Congress on TNF and Related Cytokines (1996); Distinguished Scientist Lecturer, University of Arkansas (1998); Keynote Speaker, Great Lakes Glia Meeting (1999); Chair, FASEB Summer Conference, Neural-Immune Interactions (2000, 2002); Symposium Speaker, Oklahoma Center for Neuroscience (2003); and Executive Chair, NIH Workshop on Glial Inflammation (2003).

Dr. Benveniste has served on numerous review and advisory boards. These include Member, NIH Special Section for AIDS and Related Research Review Group (1998-1991); Member, American Cancer Society: Advisory Committee for Cell Biology (1992-1995); Member, NIH Neurosciences Program Project Review Committee B (1993-1995); Chair, NIH Neurosciences Program Project Review Committee B (1995-1997); External Advisory Board, Center for Neurovirology, University of Nebraska Medical Center (1997-present); Member, National Multiple Sclerosis Society Grant Review Committee (1998-2003); Member, NIH Training Grant and Career Development Review Committee (1999-2002); Member; NIH Clinical Neuroimmunology and Brain Tumors (2000-2004); Member, Sontag Foundation Scientific Advisory Board (2003-present); Member, National Multiple Sclerosis Society, Research Programs Advisory Committee (2004-present); Chair, NIH Clinical Neu-roimmunology and Brain Tumors (2004-present); and Member, Oklahoma Medical Research Foundation Board of Scientific Visitors (2004-present). She is a member of the Editorial Boards of the Journal of Biological Chemistry, Journal of Neuroscience, GLIA, Journal of Neuroimmunology, and Journal of Neurovirology.

For the past 18 years, Dr. Benveniste's research has focused on the function of cytokines and signal transduction pathways operative in glial cells, and their contributions to CNS disease. Dr. Benveniste has received continuous research support from the NIH, NMSS, and AmFAR since 1988. She has published over 150 scientific reports and reviews, numerous book chapters, and edited two books.

Dr. Benveniste is a member of the International Society of Neuroimmunology, the American Society for Neurochemistry, the American Association of Immunolo-gists, the Society for Neuroscience, and the American Society of Cell Biology.

Dr. Benveniste is married to Dr. Casey Morrow, and they have one son, Jackson Morrow (12).

Richard M. Ransohoff is professor of molecular medicine at the Cleveland Clinic Lerner College of Medicine, a staff scientist in the Department of Neurosciences of the Lerner Research Institute, and a staff neurologist in the Mellen Center for MS Treatment and Research, both at the Cleveland Clinic Foundation (CCF), Cleveland, Ohio. He is also a professor of pathology (Adjunct) at Case Medical School. Dr. Ransohoff graduated with honors from Bard College, Annandale, New York, with a B.A. in literature and received the M.D. degree with honors from Case School of Medicine, Cleveland, Ohio. He completed residencies in internal medicine (Mt. Sinai Medical Center, Cleveland, Ohio; Board Certified 1981) and neurology (CCF; Board Certified 1985). From 1984 to 1989, Dr. Ransohoff was a postdoctoral fellow in the laboratory of Dr. Timothy Nilsen, Department of Molecular Biology and Microbiology, Case School of Medicine.

Among other honors and awards, he received a Physician's Research Training Award from the American Cancer Society (1984-1986); a Harry Weaver Neuroscience Scholarship from the National Multiple Sclerosis Society (NMSS; 1987-1992); a Clinical Investigator Development Award from the National Institutes of Health (NIH; 1988-1993); a Heritage Scholar at the University of Alberta (1998); Distinguished Lecturer at the University of Arkansas School of Medicine (2002); a recipient of the John and Samuel Bard Award in Science and Medicine (2002); and a speaker at the American Academy of Neurology's Plenary Symposium "Frontiers in Clinical Neuroscience" in 2004. He has been cited from 1996 through the present (2004) in the Best Doctors in America for his expertise in the clinical care of patients with multiple sclerosis (MS).

Dr. Ransohoff served as a regular member on NIH and National Multiple Sclerosis Society (NMSS) Study Sections; on numerous Special Emphasis Panels; and as Chair of the NMSS Peer Review Committee B from October 2004. He is a member of the editorial boards of The Journal of Immunology (where he is presently Section Editor); Trends in Immunology; Current Immunology Reviews, and the Journal of Neuroimmunology. From 1998 to 2000, Dr. Ransohoff was a member of the NINDS Director's Planning Panel on "The Neural Environment." He is a member of the Steering Committee for the NIH/NINDS Spinal Muscular Atrophy Project; the International Advisory Boards for the 7th (2004) and 8th (2006) Congresses on Neuroimmunology; and the Scientific Advisory Board for Chemocentryx, San Carlos, California. He serves on External Advisory Boards for CHARTER (CNS HIV Anti-Retroviral Therapy Effects Research; MH22005); a Program Project on Alexander's Disease (NS 42803); the MS Lesion Project (NMSS RG 3185); the University of Nebraska's Center for Neurovirology & Neurodegenerative Disorders (NS43985) and is the External Advisor for the European Union's Project on 'Mechanisms of Brain Inflammation" (QLG3-00612). He is a member of the National MS Society's Medical Advisory Board. He is a Co-director of the Marine Biological Laboratory's special topics course on "Pathogenesis of neuroimmunological disease" held biennially at Wood's Hole, Massachusetts.

For the past decade, Dr. Ransohoff's research has focused on the functions of chemokines and chemokine receptors in development and pathology of the nervous system. He also has a longstanding and continuing interest in the mechanisms of action of interferon-beta. Dr. Ransohoff has received continuous research support from the NIH and the NMSS since 1988. He has published more than 130 scientific reports, more than 35 reviews and book chapters, and three edited books.

Dr. Ransohoff is a member of the American Academy of Neurology, the American Neurological Association, the American Association for the Advancement of Science, and the American Association of Immunologists.

Dr. Ransohoff is married to Margaret Ransohoff. They have two daughters, Amy (14) and Lena (10).

10 Ways To Fight Off Cancer

10 Ways To Fight Off Cancer

Learning About 10 Ways Fight Off Cancer Can Have Amazing Benefits For Your Life The Best Tips On How To Keep This Killer At Bay Discovering that you or a loved one has cancer can be utterly terrifying. All the same, once you comprehend the causes of cancer and learn how to reverse those causes, you or your loved one may have more than a fighting chance of beating out cancer.

Get My Free Ebook


Post a comment